Načítá se...
Validating Pre-Treatment Body Mass Index as Moderator of Antidepressant Treatment Outcomes: Findings from CO-MED Trial
BACKGROUND: Currently, there are no valid clinical or biological markers to personalize the treatment of depression. Recent evidence suggests that body mass index (BMI) may guide the selection of antidepressant medications with different mechanisms of action. METHODS: Combining Medications to Enhanc...
Uloženo v:
| Vydáno v: | J Affect Disord |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312180/ https://ncbi.nlm.nih.gov/pubmed/29522941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2018.02.089 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|